These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 1318906)
1. High efficiency presentation of TNP-conjugated islet antigen to islet-specific T cells by a hybrid B cell line expressing TNP-specific surface Ig. Wegmann D; Norbury-Glaser M; Bergman B; Haskins K J Immunol; 1992 Jul; 149(1):77-82. PubMed ID: 1318906 [TBL] [Abstract][Full Text] [Related]
2. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice. Noorchashm H; Lieu YK; Noorchashm N; Rostami SY; Greeley SA; Schlachterman A; Song HK; Noto LE; Jevnikar AM; Barker CF; Naji A J Immunol; 1999 Jul; 163(2):743-50. PubMed ID: 10395666 [TBL] [Abstract][Full Text] [Related]
3. B lymphocytes are crucial antigen-presenting cells in the pathogenic autoimmune response to GAD65 antigen in nonobese diabetic mice. Falcone M; Lee J; Patstone G; Yeung B; Sarvetnick N J Immunol; 1998 Aug; 161(3):1163-8. PubMed ID: 9686575 [TBL] [Abstract][Full Text] [Related]
4. Islet-specific T cell clones transfer diabetes to nonobese diabetic (NOD) F1 mice. Peterson JD; Pike B; McDuffie M; Haskins K J Immunol; 1994 Sep; 153(6):2800-6. PubMed ID: 8077683 [TBL] [Abstract][Full Text] [Related]
5. Antigen presentation by hapten-specific B lymphocytes. II. Specificity and properties of antigen-presenting B lymphocytes, and function of immunoglobulin receptors. Abbas AK; Haber S; Rock KL J Immunol; 1985 Sep; 135(3):1661-7. PubMed ID: 2410498 [TBL] [Abstract][Full Text] [Related]
6. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse. Gallichan WS; Balasa B; Davies JD; Sarvetnick N J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077 [TBL] [Abstract][Full Text] [Related]
7. Presentation of beta-cell antigens to CD4+ and CD8+ T cells of non-obese diabetic mice. Shimizu J; Kanagawa O; Unanue ER J Immunol; 1993 Aug; 151(3):1723-30. PubMed ID: 8101546 [TBL] [Abstract][Full Text] [Related]
8. Antigen presentation by hapten-specific B lymphocytes. IV. Comparative ability of B cells to present specific antigen and anti-immunoglobulin antibody. Lichtman AH; Tony HP; Parker DC; Abbas AK J Immunol; 1987 May; 138(9):2822-5. PubMed ID: 3494773 [TBL] [Abstract][Full Text] [Related]
9. Relationship between beta cell injury and antigen presentation in NOD mice. Shimizu J; Carrasco-Marin E; Kanagawa O; Unanue ER J Immunol; 1995 Oct; 155(8):4095-9. PubMed ID: 7561122 [TBL] [Abstract][Full Text] [Related]
10. Absence of T cell tolerance to pancreatic islet cells. Burtles SS; Trembleau S; Drexler K; Hurtenbach U J Immunol; 1992 Sep; 149(6):2185-93. PubMed ID: 1355504 [TBL] [Abstract][Full Text] [Related]
11. Isolation of self antigen-reactive cells from inflamed islets of nonobese diabetic mice using CD4high expression as a marker. Lejon K; Fathman CG J Immunol; 1999 Nov; 163(10):5708-14. PubMed ID: 10553102 [TBL] [Abstract][Full Text] [Related]
12. Fusion of human B cell lines with HIV-1 envelope-expressing T cells is enhanced by antigen-specific Ig receptors. Possible mechanism for elimination of gp120-specific B cells in vivo. Golding H; Dimitrov DS; Blackburn R; Manischewitz J; Blumenthal R; Golding B J Immunol; 1993 Mar; 150(6):2506-16. PubMed ID: 7680694 [TBL] [Abstract][Full Text] [Related]
13. B lymphocytes are critical antigen-presenting cells for the initiation of T cell-mediated autoimmune diabetes in nonobese diabetic mice. Serreze DV; Fleming SA; Chapman HD; Richard SD; Leiter EH; Tisch RM J Immunol; 1998 Oct; 161(8):3912-8. PubMed ID: 9780157 [TBL] [Abstract][Full Text] [Related]
14. Activation of autoreactive T-cell clones from NZB.H-2bm12 mice. Naiki M; Yoshida SH; Ansari AA; Bill J; Gershwin ME J Autoimmun; 1994 Jun; 7(3):275-90. PubMed ID: 7916904 [TBL] [Abstract][Full Text] [Related]
15. Role of inflammatory infiltrate in activation and effector function of cloned islet reactive nonobese diabetic CD8+ T cells: involvement of a nitric oxide-dependent pathway. Gurlo T; Kawamura K; von Grafenstein H J Immunol; 1999 Dec; 163(11):5770-80. PubMed ID: 10570259 [TBL] [Abstract][Full Text] [Related]
16. On the pathogenicity of autoantigen-specific T-cell receptors. Burton AR; Vincent E; Arnold PY; Lennon GP; Smeltzer M; Li CS; Haskins K; Hutton J; Tisch RM; Sercarz EE; Santamaria P; Workman CJ; Vignali DA Diabetes; 2008 May; 57(5):1321-30. PubMed ID: 18299317 [TBL] [Abstract][Full Text] [Related]
17. Characterization of a human T cell line reactive to a 52 kDa islet protein. Sobel DO; Fleisher T; Karounos DG J Autoimmun; 1997 Aug; 10(4):387-94. PubMed ID: 9237802 [TBL] [Abstract][Full Text] [Related]
18. Establishment of islet-specific T-cell lines and clones from islet isografts placed in spontaneously diabetic NOD mice. Wegmann DR; Shehadeh N; Lafferty KJ; Norbury-Glaser M; Gill RG; Daniel D J Autoimmun; 1993 Oct; 6(5):517-27. PubMed ID: 7902094 [TBL] [Abstract][Full Text] [Related]
19. The preferential ability of B lymphocytes to act as diabetogenic APC in NOD mice depends on expression of self-antigen-specific immunoglobulin receptors. Silveira PA; Johnson E; Chapman HD; Bui T; Tisch RM; Serreze DV Eur J Immunol; 2002 Dec; 32(12):3657-66. PubMed ID: 12516557 [TBL] [Abstract][Full Text] [Related]
20. Inhibition by brefeldin A of the specific B cell antigen presentation to MHC class II-restricted T cells. Kakiuchi T; Takatsuki A; Watanabe M; Nariuchi H J Immunol; 1991 Nov; 147(10):3289-95. PubMed ID: 1940337 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]